TIGASOL INJ

Product Description

TIGASOL INJ is a premium injectable formulation containing Tigecycline 50mg, a broad-spectrum glycylcycline antibiotic known for its potent activity against multidrug-resistant (MDR) bacterial infections. Specially designed for hospital use and critical care, TIGASOL INJ offers a powerful solution for the treatment of complicated intra-abdominal infections, skin and soft tissue infections, and certain drug-resistant respiratory tract infections.

Formulated under WHO-GMP certified conditions, TIGASOL INJ is ideal for medical distributors, bulk pharmaceutical buyers, and hospital procurement departments seeking reliable, high-efficacy injectable antibiotics.

Key Benefits:

• Contains Tigecycline 50mg effective against MDR pathogens

• Ideal for ICU settings and hospital-based infection management

• Broad-spectrum coverage including MRSA, VRE, and ESBL-producing organisms

• Stable, ready-to-use vial for intravenous administration

• Backed by quality assurance and strict manufacturing protocols

Indications:

• Complicated intra-abdominal infections (cIAIs)

• Complicated skin and soft tissue infections (cSSTIs)

• Effective against community-acquired bacterial pneumonia (CABP)

Why Choose TIGASOL INJ?

• Trusted in critical care antibiotic therapy

• High demand among hospital pharmacists and institutional buyers

• Suitable for bulk orders, tenders, and pharma B2B trade

• Prompt delivery and competitive pricing for distributors